Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 4

1.

A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.

Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung HP, Krantz M, Ferenczi L, Verco T; MAESTRO-01 Investigators.

Neurology. 2011 Oct 18;77(16):1551-60. doi: 10.1212/WNL.0b013e318233b240. Epub 2011 Oct 5.

PMID:
21975206
[PubMed - indexed for MEDLINE]
2.

Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea.

Tuomilehto HP, Seppä JM, Partinen MM, Peltonen M, Gylling H, Tuomilehto JO, Vanninen EJ, Kokkarinen J, Sahlman JK, Martikainen T, Soini EJ, Randell J, Tukiainen H, Uusitupa M; Kuopio Sleep Apnea Group.

Am J Respir Crit Care Med. 2009 Feb 15;179(4):320-7. doi: 10.1164/rccm.200805-669OC. Epub 2008 Nov 14.

PMID:
19011153
[PubMed - indexed for MEDLINE]
3.

Serum amino acid concentrations in aging men and women.

Pitkänen HT, Oja SS, Kemppainen K, Seppä JM, Mero AA.

Amino Acids. 2003 Jun;24(4):413-21.

PMID:
12768504
[PubMed - indexed for MEDLINE]
4.

[Conversion hysterical paralysis in a young woman].

Karlsson H, Saarijärvi S, Seppä JM.

Duodecim. 1990;106(18):1273-6. Finnish. No abstract available.

PMID:
1670558
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk